Description
Release form
Capsules.
Packing
100 pcs.
Indications
Fatty liver degeneration of various etiologies
chronic hepatitis
toxic liver damage
cirrhosis of the liver
hypercholesterolemia, with an ineffective diet and other non-drug measures (physical activity and measures to reduce body weight).
Contraindications
Hypersensitivity to phospholipids, peanuts, soy and other components of the drug
antiphospholipid syndrome.
Caution: children under 12 years old.
Pregnancy and lactation
There are no data on the safety of the drug during pregnancy. Therefore, Rezalyut ® Pro should only be used if the intended benefit to the mother outweighs the potential risk to the fetus.
There is no data on the penetration of the drug Rezalyut ® Pro into breast milk, therefore, if it is necessary to use the drug Rezalyut ® Pro during lactation, breastfeeding should be discontinued.
Composition
1 capsule contains:
Active substances: PPL lipid 600 600 mg, consisting of: polyunsaturated phospholipids from soya lecithin 300 mg glycerol mono / dialconate (C14-C18) 120 mg medium chain triglycerides 40.5 mg 138.5 mg? -Tocopherol 1.0 mg.
Excipients: refined soybean oil.
Composition of capsule shell: gelatin, glycerol 85%.
Dosage and administration
The drug is intended for oral administration.
Unless otherwise indicated, take 2 caps. Rezalyut ® Pro 3 times / day before meals, without chewing and drinking plenty of fluids.
The duration of treatment depends on the course of the disease.
Side effects
From the digestive system: discomfort in the epigastric region, diarrhea can sometimes occur.
Allergic reactions: in rare cases, skin rash, urticaria.
From the hemopoietic system: extremely rarely – petechial rashes, bleeding in women during the menstrual period.
Drug Interaction
Incompatibilities have not yet been reported.
However, the interaction of Resalut ® Pro with coumarin anticoagulants (eg phenprocoumon, warfarin) cannot be excluded. If appropriate combination therapy is unavoidable, it may be necessary to adjust the dosage of the drug.
Overdose
There have been no reports of overdose and intoxication with the drug so far.
Storage conditions
Keep out of the reach of children, at a temperature not exceeding 25 ° C.
Expiration
2 years.
Active ingredient
Phospholipids
over-the-counter pharmacies
form
dosage form
capsules
